跳至主要内容
临床试验/NCT03968991
NCT03968991终止不适用

VISIODOL: Validation of the VISIODOL® Scale for Screening of Pain in People With Visual Impairment

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2019年6月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
37
试验地点
1
主要终点
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.

研究概览

简要总结

The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.

详细描述

The VISIODOL® monocentric study conducted at Clermont-Ferrand University Hospital is a cross-disciplinary diagnostic tool validation performed in patients with acquired or congenital visual impairment and healthy sighted volunteers. Different evaluations by thermal (Pathway Médoc®) and mechanical (electronic Von Frey®) tests will allow to compare the new VISIODOL® scale with the numerical scale, which is a commonly used tool. The ergonomic quality, the satisfaction of use and the quality of life, stress, anxiety and catastrophism of the patients will also be studied.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy volunteers
  • •Subjects aged over 18 / under 60
  • •Male or female
  • •Subjects fasting from coffee, tea, Coca-Cola and others stimulants
  • •Sufficient understanding and cooperation to comply with the study requirements
  • •Agreed to provide written consent
  • •Affiliated to the social security
  • •Subjects with visual impairment (congenital or acquired)
  • •Subjects with no visual impairment (healthy group)

排除标准

  • •Subjects under 18 years old
  • •Administrative and legal criteria (tutorship, curatorship, without social security, in exclusion period of another study)

研究组 & 干预措施

Subjects with congenital visual impairment

Experimental

Visual congenital disability

干预措施: VISIODOL® (Diagnostic tool) (Diagnostic Test)

Healthy volunteer group

Active Comparator

male or female healthy volunteers

干预措施: VISIODOL® (Diagnostic tool) (Diagnostic Test)

Subjects with acquired visual impairment

Experimental

visual acquired disability

干预措施: VISIODOL® (Diagnostic tool) (Diagnostic Test)

结局指标

主要结局

Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.

时间窗: Day 0 + 2 hours

Determination of the correlation coefficient between NS and VISIODOL® scale for different pain temperatures by hot thermal tests. The rating of the NS and VISIODOL® scales can range from 0 to 10.

次要结局

  • Evaluation of satisfaction of the use of the scale(Day 0 + 1 hour)
  • Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.(Day 0 + 2 hours)
  • Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using mechanical tests.(Day 0 + 2 hours)
  • Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests .(Day 0 + 2 hours)
  • Comparison of pain perception between the 3 groups(Day 0 + 1 hour)
  • Evaluation of the ergonomic qualities of the scale(Day 0 + 1 hour)
  • Evaluation of anxiety(Day 0 + 1 hour)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验